Evaluation of the prediction ability of preeclampsia complications through the use of the risk factor scale for preeclampsia complications and the fullPIERS scale in a hospital in Lima

Authors

DOI:

https://doi.org/10.17843/rpmesp.2025.421.14041

Keywords:

Preeclampsia, Pregnancy complications, Pregnancy

Abstract

Objectives. To evaluate the ability of the Risk Factor Scale for Preeclampsia Complications (RFSPC) and the
fullPIERS (Pre-eclampsia Integrated Estimate of RiSk) scale to predict complications of preeclampsia in pregnant women diagnosed with preeclampsia who were admitted to the obstetrics and gynecology department of a referral hospital, from October 2021 to December 2022. Materials and methods. This was a retrospective cohort design study. Data was collected from the medical records of patients diagnosed with preeclampsia, and both scales (RFSPC and fullPIERS) were applied. With these results, the sensitivity, specificity and the area under the ROC curve (AUC) were obtained by taking different cut-off points. The best score was selected as the one with the highest AUC. The differences between the scales were explored by comparing their AUCs. Results. We included 367 pregnant women. The RFSPC had a sensitivity of 71%, a specificity of 73% and an AUC of 0.722 with a cutoff point of 3 points. Whereas the fullPIERS scale showed 76%, 84% and 0.804 respectively with a cutoff point of 0.75%. Conclusions. Both scales can be useful for identifying pregnant women at risk of complications with cutoff points different from those defined internationally.

Downloads

Download data is not yet available.

References

Hladunewich M, Karumanchi SA, Lafayette R. Pathophysiology of the clinical manifestations of preeclampsia. Clin J Am Soc Nephrol.

;2(3):543–9. doi: 10.2215/CJN.03761106.

Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135(6):e237–60. doi:

1097/AOG.0000000000003891.

Williams Obstetricia, 25e, AccessMedicina, McGraw Hill Medical. [citado el 13 de noviembre de 2024]. Disponible en https://accessmedicina.mhmedical.com/content.aspx?bookId=2739&sectionId=228704755.

Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet.

;367(9516):1066–74. doi: 10.1016/S0140-6736(06)68397-9.

Villar J, Carroli G, Wojdyla D, Abalos E, Giordano D, Ba’aqeel H, et al. Preeclampsia, gestational hypertension and intrauterine growth

restriction, related or independent conditions? Am J Obstet Gynecol. 2006;194(4):921–31. doi: 10.1016/j.ajog.2005.10.813.

Quispe-De La Cruz R, Quispe-Dolorier J, Zegarra-Jibaja P. Complicaciones maternas y fetales de la Preeclampsia diagnosticadas en un

hospital del sur del Perú, 2013. Rev Méd Panacea. 2014; 4(1): 3-7. doi: 10.35563/rmp.v4i1.160

Ganzevoort W, Rep A, Bonsel GJ, Fetter WPF, van Sonderen L, De Vries JIP, et al. A randomised controlled trial comparing two temporising management strategies, one with and one without plasma volume expansion, for severe and early onset pre-eclampsia. BJOG. 2005;112(10):1358–68. doi: 10.1111/j.1471-0528.2005.00687.x.

Von Dadelszen P, Payne B, Li J, Ansermino JM, Pipkin FB, Côté A-M, et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet. 2011;377(9761):219–27. doi: 10.1016/S0140-6736(10)61351-7

fullPIERS | PRE-EMPT | Department of Obstetrics & Gynaecology [Internet]. Pre-empt.obgyn.ubc.ca. 2022 [citado el 10 de junio de 2022]. Disponible en: https://pre-empt.obgyn.ubc.ca/home-page/past-projects/fullpiers/

Elizalde-Valdés VM, Téllez-Becerril GE, López-Aceves LJ. Construcción y validación de una escala de factores de riesgo para complicaciones de preeclampsia. Clin Invest Ginecol Obstet. 2016;43(3):110–21. doi:10.1016/j.gine.2014.12.013

Calsin-Quispe AR. Valor pronóstico de la escala FULLPIERS para el síndrome de HELLP en gestantes con preeclampsia severa. Hospital Carlos Monge Medrano 2018-2019. [tesis de médico cirujano]. Piura: Escuela Profesional de Medicina, Universidad Cesar Vallejo; 2020. Disponible en: https://repositorio.ucv.edu.pe/handle/20.500.12692/57863.

Ministerio de Salud. Plan Operativo Institucional (POI) Multianual 2025 – 2027 [Internet]. [citado el 13 de noviembre de 2024]. Disponible en: https://www.gob.pe/institucion/reniec/informes-publicaciones/5631348-plan-operativo-institucional-poi-multianual-2025-2027.

Ministerio de Salud. ANÁLISIS DE LA SITUACIÓN DE SALUD HOSPITALARIA (ASISHO) DEL HOSPITAL NACIONAL CAYETANO

HEREDIA 2023 [Internet]. [citado el 13 de noviembre de 2024]. Disponible en: https://www.gob.pe/institucion/hnch/normas-legales/

-324-2023-hnch-dg.

Espinoza J, Vidaeff A, Pettker C, Simhan H. Gestational Hypertension and preeclampsia: ACOG Practice Bulletin Summary, Number 222. Obstet Ginecol 2020, 135(6):1492-1495. doi: 10.1097/AOG.0000000000003892.

Arifin WN. Sample size calculator (Version 2.0) [Spreadsheet file]. Author: 2017. Disponible en: http://wnarifin.github.io

Buderer NM. Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity - Acad Emerg Med. 1996;3(9):895-900. doi: 10.1111/j.1553-2712.1996.tb03538.x.

Muñoz-Salazar AM. Estudio clínico de eclampsia, en el Hospital José Agurto Tello de Chosica - Lima, Perú entre los años 2004–2009. [tesis de médico cirujano]. Lima: Facultad de Medicina Humana, Universidad Ricardo Palma. 2011. Disponible en: https://hdl.handle.net/20.500.14138/321

Ramos MG. Mortalidad materna, ¿cambiando la causalidad el 2021? Rev Peru Ginecol Obstet. 2022;68(1):1-3. doi: 10.31403/rpgo.v68i2407

Ukah UV, Payne B, Hutcheon JA, Ansermino JM, Ganzevoort W, Thangaratinam S, et al. Assessment of the fullPIERS Risk Prediction Model in Women With Early-Onset Preeclampsia. Hypertension. 2018;71(4):659–65. doi: 10.1161/HYPERTENSIONAHA.117.10318.

Boutot M, Margueritte F, Boukeffa N, Coste Mazeau P, Aubard Y, Gauthier T. External validation of FullPIERS model for prediction of adverse outcomes among women with pre-eclampsia in French maternity of 2014 to 2018. Gynecol Obstet Fertil Senol. 2020;48(2):167–73. doi: 10.1016/j.gofs.2020.01.0021.

Almeida ST, Katz L, Coutinho I, Amorim MMR. Validation of full-PIERS model for prediction of adverse outcomes among women with

severe pre-eclampsia. Int J Gynaecol Obstet. 2017;138(2):142–7. doi: 10.1002/ijgo.12197.

Downloads

Published

2025-02-19

Issue

Section

Original Article

How to Cite

1.
Aquino-Vásquez PN, Chuquipoma-Zanabria LG, Lazo-Porras M, Flores-Noriega M. Evaluation of the prediction ability of preeclampsia complications through the use of the risk factor scale for preeclampsia complications and the fullPIERS scale in a hospital in Lima. Rev Peru Med Exp Salud Publica [Internet]. 2025 Feb. 19 [cited 2025 Mar. 12];42(1). Available from: https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/14041

Most read articles by the same author(s)